New Enterprise Associates related stories
All articles and analysis
NVCA appoints True Ventures' Callaghan as chairmanThe National Venture Capital Association has named Jon Callaghan chairman of its board of directors. A founder and general partner of True Ventures, Callaghan is succeeding Scott Sandell, general partner of New Enterprise Associates. In addition to this appointment, ten new board members were announced at NVCA's annual meeting held in San Francisco. Among them are Mike Carusi, general partner of Lightstone Ventures; Jeff Clavier, founder and managing director of SoftTech VC; Michael Dixon, a partner at Sequoia Capital; and Mary Meeker, a partner at Kleiner Perkins Caufield & Byers.
- VC-backed Adaptimmune rolls out IPO
UK and Philadelphia-based biotechnology company Adaptimmune Therapeutics plc has debuted its IPO after pricing its 11.25 million shares at $17 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol "ADAP." BofA Merrill Lynch, Cowen and Company and Leerink Partners LLC are serving as the lead underwriters. Adaptimmune's backers include New Enterprise Associates, OrbiMed Advisors, Wellington Management Company, Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management and Rock Springs Capital.
- CIT Gap invests in e-Kare Inc
The Center for Innovative Technology said Wednesday that its CIT GAP funds have invested in e-Kare Inc. Financial terms weren’t announced. Fairfax, Virginia-based e-Kare has developed a point-of-care subscription service that allows for 3-dimensional wound assessment on a mobile device.
- CRISPR Therapeutics raises $64 mln
CRISPR Therapeutics said Wednesday it raised $64 million in financing, including $35 million in a Series A and $29 million in a Series B. Strategic investors, SR One and Celgene Corp., led the rounds while new investors New Enterprise Associates and Abingworth, alongside the Company’s founding investor, Versant Ventures, also participated. CRISPR Therapeutics, of Basel, Switzerland, is a biopharmaceutical company.
- Venture fundraising keeps strong pace in Q1
U.S.-based firms raised more than $7.3 billion during the quarter, which is not far off of the record pace last year
- Xplore closes buy of VC-backed Motion Computing
Xplore Technologies Corp. has completed its previously announced acquisition of substantially all of the assets of Austin, Texas-based Motion Computing Inc, a maker of rugged tablet PCs. The value of the transaction is about $9 million, which includes $7 million in net liabilities. Motion Computing's backers included New Enterprise Associates, Institutional Venture Partners and G-51 Capital.
peHUB First ReadFirst Read ends your week with news Google is reportedly investing an additional $1 bln in a giant Iowa data center, Oil services firm Schlumberger lays off 11,000 and the Fed is shying away from raising rates in June.
Menlo shows big gains in Washington State portfolio--VCJ fund performance reportDistributions rise from Austin, NEA, Menlo for Washington State Investment Board’s venture portfolio.
NEA goes large, raising $3.15 billion in new capitalThe tech and healthcare investor raises $2.8 billion for its largest ever fund and $350 million for its first opportunity fund
NEA raises $2.8 bln for its largest ever fund and $350 mln for its first opportunity fundNew Enterprise Associates goes large, raising $3.15 in new capital, including $2.8 billion for its largest ever fund and $350 million for its first opportunity fund.